The vision of the Molecular Discovery Core (MDC) is to build a highly collaborative and state-of-the-art facility at the Phoenix Biomedical Campus to accelerate early-stage drug discovery in the Arizona research community with several instruments geared toward the analysis of biomolecules.
This core supports a wide variety of research activities that depend on the detection and analysis of proteins, nucleic acids, compounds, bioactive molecules, and biomolecular interactions.
Due to the COVID-19 outbreak and staffing restrictions, the core will unfortunately be unable to provide assisted services for the immediate future. This includes assisted SPR, peptide synthesis, LC-MS and any other assisted work. Unassisted usage is still open. Please contact Dr. Timothy Marlowe for further questions and we will update all users upon restoration of full core services.
Surface Plasmon Resonance (SPR)
- Kinetic characterization.
- Small molecule/fragment screening.
- Assay design & optimization.
- Binding affinity analysis.
- Compound screening in 96- and 384-well format.
- Assay automation.
- Plate replication/reformatting.
- Processing of clinical samples.
- In silico screening.
Peptide Synthesis & HPLC
- Solid-phase peptide synthesis.
- Compound/peptide purification by HPLC.
- Analytical HPLC.
- Fluorescence, chemiluminescence, radioisotopic, colorimetric.
- Imaging of blots, gels, tissue sections, arrays, and phosphor screens.